ENZON HEADER PIC
Manufacturing Capabilities
  • In addition to our efforts to develop and commercialize innovative products for life threatening diseases, we are also ideally positioned to offer prospective contract manufacturing partners the following credentials:
  • A proven track record in the development and manufacture of complex products including aseptic manufacture of liposomal products
  • Large-scale manufacturing expertise, including a 56,000 square foot, sterile injectable manufacturing facility with fill, finish and packaging capabilities
  • Cutting-edge chemistry and microbiology laboratories with isolator technology
  • An experienced management team with a track record of successfully developing and commercializing pharmaceutical products
  • An excellent regulatory compliance history
  • Fully integrated manufacturing including formulation, fill, finish, packaging and product release

    • From the time an inquiry is received through the final quality control testing and release, the project receives the dedicated attention of our business development and project management teams.

    Enzon Completes Sale of Speciality Pharmaceutical Business

    Enzon Pharmaceuticals, Inc. has closed the sale of its specialty pharmaceutical business to sigma-tau. The specialty pharmaceutical business sold includes four marketed products, Abelcet® (amphotericin B lipid complex injection), Adagen® (pegademase bovine), Depocyt® (cytarabine liposome injection), and Oncaspar® (pegaspargase), as well as the manufacturing facility in Indianapolis, Indiana. In the future, please refer to www.sigmatau.com for information regarding these products and services.

    Enzon is continuing to assist sigma-tau in supporting these products for a limited time. Enzon’s Medical Information hotline (866-792-5172) and Drug Safety hotline (800-836-4301) are available to receive questions or adverse event reports.

    Investor Relations
    Investors
    For analyst coverage, annual reports, or to request information about Enzon
    CLICK HERE